Tania Ahuja

1.1k total citations
59 papers, 585 citations indexed

About

Tania Ahuja is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Tania Ahuja has authored 59 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cardiology and Cardiovascular Medicine, 23 papers in Internal Medicine and 14 papers in Surgery. Recurrent topics in Tania Ahuja's work include Venous Thromboembolism Diagnosis and Management (23 papers), Atrial Fibrillation Management and Outcomes (22 papers) and Cardiac electrophysiology and arrhythmias (6 papers). Tania Ahuja is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (23 papers), Atrial Fibrillation Management and Outcomes (22 papers) and Cardiac electrophysiology and arrhythmias (6 papers). Tania Ahuja collaborates with scholars based in United States, Finland and United Kingdom. Tania Ahuja's co-authors include John Papadopoulos, Christopher M. Petrilli, Simon Jones, Joseph Rahimian, Philip M. Carlucci, Eugene Yuriditsky, James M. Horowitz, David Green, Shadi Yaghi and Jeffrey S. Berger and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Tania Ahuja

51 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tania Ahuja United States 11 245 166 152 120 91 59 585
Ragheb Assaly United States 15 253 1.0× 138 0.8× 27 0.2× 134 1.1× 138 1.5× 79 776
Sébastian Voicu France 16 237 1.0× 267 1.6× 83 0.5× 83 0.7× 124 1.4× 63 842
Maaike A. Sikma Netherlands 14 245 1.0× 49 0.3× 67 0.4× 85 0.7× 40 0.4× 31 737
Yuehong Hu China 9 77 0.3× 72 0.4× 86 0.6× 37 0.3× 74 0.8× 22 382
Siddharth Dugar United States 14 123 0.5× 116 0.7× 26 0.2× 77 0.6× 219 2.4× 62 690
Fabrizio Colombo Italy 11 110 0.4× 133 0.8× 38 0.3× 74 0.6× 82 0.9× 38 435
Deepak Govil India 11 170 0.7× 24 0.1× 40 0.3× 121 1.0× 81 0.9× 52 538
Alicia Lorenzo Spain 14 189 0.8× 162 1.0× 224 1.5× 8 0.1× 68 0.7× 44 645
Tyler Lewis United States 12 87 0.4× 90 0.5× 25 0.2× 49 0.4× 78 0.9× 31 478
Sunil Sethi Singapore 16 162 0.7× 196 1.2× 10 0.1× 50 0.4× 164 1.8× 40 975

Countries citing papers authored by Tania Ahuja

Since Specialization
Citations

This map shows the geographic impact of Tania Ahuja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tania Ahuja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tania Ahuja more than expected).

Fields of papers citing papers by Tania Ahuja

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tania Ahuja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tania Ahuja. The network helps show where Tania Ahuja may publish in the future.

Co-authorship network of co-authors of Tania Ahuja

This figure shows the co-authorship network connecting the top 25 collaborators of Tania Ahuja. A scholar is included among the top collaborators of Tania Ahuja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tania Ahuja. Tania Ahuja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krittanawong, Chayakrit, Tania Ahuja, Zhen Wang, et al.. (2025). Bivalirudin Versus Heparin in Patients Undergoing Percutaneous Coronary Intervention in Acute Coronary Syndromes. Critical Pathways in Cardiology A Journal of Evidence-Based Medicine. 24(1). e0372–e0372. 1 indexed citations
2.
Yuriditsky, Eugene, et al.. (2025). The latest in the management of pulmonary embolism. Breathe. 21(2). 240100–240100.
3.
Krittanawong, Chayakrit, et al.. (2025). BIVALIRUDIN VERSUS HEPARIN IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN ACUTE CORONARY SYNDROMES. Journal of the American College of Cardiology. 85(12). 949–949. 1 indexed citations
4.
Ahuja, Tania, et al.. (2024). Anticoagulant prescribing patterns in patients with primary central nervous system malignancies and secondary metastases. Journal of Thrombosis and Thrombolysis. 57(3). 418–427. 1 indexed citations
5.
Papadopoulos, John, et al.. (2024). Balancing the Interactions: Assessing Antiplatelet and Antiretroviral Therapy Drug–Drug Interactions in People Living With HIV. Journal of Cardiovascular Pharmacology. 85(1). 75–83. 3 indexed citations
6.
Ahuja, Tania, John Papadopoulos, Samuel Bernard, et al.. (2024). Digoxin Loading Doses and Serum Digoxin Concentrations for Rate Control of Atrial Arrhythmias in Critically Ill Patients. Journal of Cardiovascular Pharmacology. 85(3). 211–216.
7.
Yuriditsky, Eugene, et al.. (2023). Anti‐factor Xa as the preferred assay to monitor heparin for the treatment of pulmonary embolism. International Journal of Laboratory Hematology. 46(2). 354–361. 5 indexed citations
8.
Ahuja, Tania, et al.. (2023). To Measure or Not to Measure: Direct Oral Anticoagulant Laboratory Assay Monitoring in Clinical Practice. Advances in Hematology. 2023. 1–7. 6 indexed citations
9.
Leiva, Orly, et al.. (2023). Off-Target Effects of Cancer Therapy on Development of Therapy-Induced Arrhythmia: A Review. Cardiology. 148(4). 324–334. 9 indexed citations
10.
Ahuja, Tania, et al.. (2023). To PLEX or Not to PLEX for Amiodarone-Induced Thyrotoxicosis. SHILAP Revista de lepidopterología. 2023. 1–4.
11.
Ahuja, Tania, C. Gidea, Alex Reyentovich, et al.. (2021). Comparison of Outcomes of Enoxaparin Bridge Therapy in HeartMate II versus HeartWare HVAD Recipients. Journal of Cardiovascular Pharmacology and Therapeutics. 26(5). 473–479. 3 indexed citations
12.
Carlucci, Philip M., et al.. (2020). Zinc sulfate in combination with a zinc ionophore may improve outcomes in hospitalized COVID-19 patients. Journal of Medical Microbiology. 69(10). 1228–1234. 122 indexed citations
13.
Berger, Jeffrey S., Dennis Kunichoff, Samrachana Adhikari, et al.. (2020). Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients With COVID-19. Arteriosclerosis Thrombosis and Vascular Biology. 40(10). 2539–2547. 116 indexed citations
14.
Ahuja, Tania, et al.. (2020). Perils of Antithrombotic Transitions: Effect of Oral Factor Xa Inhibitors on the Heparin Antifactor Xa Assay. Therapeutic Drug Monitoring. 42(5). 737–743. 1 indexed citations
15.
16.
Frontera, Jennifer, et al.. (2019). Cost comparison of andexanet versus prothrombin complex concentrates for direct factor Xa inhibitor reversal after hemorrhage. Journal of Thrombosis and Thrombolysis. 49(1). 121–131. 54 indexed citations
17.
Ahuja, Tania, et al.. (2018). Assessment of patients post reversal with idarucizumab. Journal of Thrombosis and Thrombolysis. 46(4). 466–472. 8 indexed citations
18.
Ahuja, Tania, et al.. (2018). Enoxaparin Dosing and AntiXa Monitoring in Specialty Populations: A Case Series of Renal-Impaired, Extremes of Body Weight, Pregnant, and Pediatric Patients.. PubMed Central. 43(10). 609–614. 4 indexed citations
19.
Ahuja, Tania, et al.. (2017). Anticoagulation prescribing patterns in patients with cancer. Journal of Thrombosis and Thrombolysis. 45(1). 89–98. 19 indexed citations
20.
Holzman, Robert S., Yanina Dubrovskaya, Tania Ahuja, et al.. (2014). Extended-Infusion versus Standard-Infusion Piperacillin-Tazobactam for Sepsis Syndromes at a Tertiary Medical Center. Antimicrobial Agents and Chemotherapy. 58(8). 4470–4475. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ragheb Assaly Breakdown of academic impact, for papers by Sébastian Voicu Breakdown of academic impact, for papers by Maaike A. Sikma Breakdown of academic impact, for papers by Yuehong Hu Breakdown of academic impact, for papers by Siddharth Dugar Breakdown of academic impact, for papers by Fabrizio Colombo Breakdown of academic impact, for papers by Deepak Govil Breakdown of academic impact, for papers by Alicia Lorenzo Breakdown of academic impact, for papers by Tyler Lewis Breakdown of academic impact, for papers by Sunil Sethi
Rankless by CCL
2026